Editorial. Methotrexate for Wegener's granulomatosis: What is the evidence?

Research output: Contribution to journalArticle

21 Citations (Scopus)
Original languageEnglish (US)
Pages (from-to)2237-2242
Number of pages6
JournalArthritis and Rheumatism
Volume52
Issue number8
DOIs
StatePublished - Aug 2005

Fingerprint

Granulomatosis with Polyangiitis
Antirheumatic Agents
Evidence-Based Medicine
Methotrexate

ASJC Scopus subject areas

  • Immunology
  • Rheumatology

Cite this

Editorial. Methotrexate for Wegener's granulomatosis : What is the evidence? / Specks, Ulrich.

In: Arthritis and Rheumatism, Vol. 52, No. 8, 08.2005, p. 2237-2242.

Research output: Contribution to journalArticle

@article{4863d4fea5714788a8b5880c11f65f61,
title = "Editorial. Methotrexate for Wegener's granulomatosis: What is the evidence?",
author = "Ulrich Specks",
year = "2005",
month = "8",
doi = "10.1002/art.21146",
language = "English (US)",
volume = "52",
pages = "2237--2242",
journal = "Arthritis and Rheumatology",
issn = "2326-5191",
publisher = "John Wiley and Sons Ltd",
number = "8",

}

TY - JOUR

T1 - Editorial. Methotrexate for Wegener's granulomatosis

T2 - What is the evidence?

AU - Specks, Ulrich

PY - 2005/8

Y1 - 2005/8

UR - http://www.scopus.com/inward/record.url?scp=23644441524&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=23644441524&partnerID=8YFLogxK

U2 - 10.1002/art.21146

DO - 10.1002/art.21146

M3 - Article

C2 - 16052540

AN - SCOPUS:23644441524

VL - 52

SP - 2237

EP - 2242

JO - Arthritis and Rheumatology

JF - Arthritis and Rheumatology

SN - 2326-5191

IS - 8

ER -